Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation

Author:

Sun Guodong12ORCID,Jian Weilin3,Luo Zhonghua3,Sun Tengfei3,Li Chao3,Zhang Jiancun1,Wang Zhongqing34ORCID

Affiliation:

1. Guangzhou Institutes of Biomedicine and Heath, Chinese Academy of Sciences, 190 Kaiyuan Road, Guangzhou 510530, P.R. China

2. University of Chinese Academy of Sciences, No. 19 Yuquan Road, Beijing 100049, P.R. China

3. HEC Research and Development Center, HEC Pharm Group, Dongguan 523871, P.R. China

4. Anti-infection Innovation Department, New Drug Research Institute, HEC Pharma Group, Dong Guan 523871, P.R. China

Funder

Anti-infective Drug National Key Laboratory

Key Science & Technology Brainstorm Project of Dongguan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference28 articles.

1. Eliglustat tartrate

2. Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease

3. Eliglustat: First Global Approval

4. aHirth, B. H.; Siegel, C. Synthesis of UDP-glucose: N-Acylsphingosineglucosyltransferase inhibitors. Patent Appl. WO03008399 A1, 2003.

5. bWang, B. N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors. Patent Appl. WO2015065937 A1, 2015.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3